Standardized price information is a vital part of the drug purchasing/supply system. Visibility into true acquisition cost is the first step to containing prescription drug costs. Until now, the lack of transparency has made tracking drug acquisition costs all but impossible. But a new price type, Predictive Acquisition Cost (PAC), tracks true acquisition cost more closely than AWP or any other existing or proposed price type.
Prevent over-paying, contain costs, and ultimately provide better health benefits using PAC, the only drug price type that meets all of the industry-defined criteria for a new drug price benchmark:
- Transparency
- Accessibility
- Comprehensiveness
- Timeliness
- Immunity to Manipulation
- Administratively Simple
